Omeros' OMIDRIA Eye Drop OK'ed For Pediatric Use
December 12, 2017 at 10:12 AM EST
Omeros Corporation (NASDAQ: OMER) shares are trading higher Tuesday after the commercial-stage biopharma company announced FDA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.